There is no doubt that Exponent Inc (EXPO) ticks all the boxes.

With 0.17 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.23 million shares. During the session, the Engineering & Construction company that operates in wider Industrials sector, reached to the highest price of $94.04 whereas the lowest price it dropped to was $91.58. The 52-week range on EXPO shows that it touched its highest point at $115.75 and its lowest point at $68.70 during that stretch. It currently has a 1-year price target of $116.00. With its current market cap of 4.69 billion, EXPO has annualized dividend of $1.12 while the current yield stands at 1.21%. EXPO paid its most recent dividend on 1733443200, while the ex-dividend date for that was 1733443200. Beta for the stock currently stands at 0.71.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of EXPO was up-trending over the past week, with a rise of 3.59%, but this was down by -0.77% over a month. Three-month performance dropped to -19.37% while six-month performance fell -11.25%. The stock gained 4.05% in the past year, while it has gained 3.64% so far this year. A look at the trailing 12-month EPS for EXPO yields 2.06 with Next year EPS estimates of 2.11. For the next quarter, that number is 0.40. This implies an EPS growth rate of 6.26% for this year and 2.14% for next year.

Float and Shares Shorts:

At present, 50.77 million EXPO shares are outstanding with a float of 50.22 million shares on hand for trading. On 2024-12-31, short shares totaled 1.61 million, which was 317.0 higher than short shares on 1732838400. In addition to Dr. Catherine Ford Corrigan P.E., Ph.D. as the firm’s President, CEO & Director, Mr. Richard L. Schlenker Jr. serves as its Executive VP, CFO & Corporate Secretary.

Institutional Ownership:

Through their ownership of 0.94921 of EXPO’s outstanding shares, institutional investors have minority control over the company.

An Overview of Recent Financials:

Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-09-27, EXPO reported revenue of $136279000.0 and operating income of $25847000.0. The EBITDA in the recently reported quarter was $28236000.0 and diluted EPS was $0.5.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for EXPO since 1 analysts follow the stock currently. There are 0 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With EXPO analysts setting a high price target of 120.0 and a low target of 112.0, the average target price over the next 12 months is 116.0. Based on these targets, EXPO could surge 29.95% to reach the target high and rise by 21.29% to reach the target low. Reaching the average price target will result in a growth of 25.62% from current levels.

Analysts have provided yearly estimates in a range of $2.09108 being high and $2.03754 being low. For EXPO, this leads to a yearly average estimate of $2.0615.